NCT05126823

Brief Summary

Introduction: emotional and physical alterations frequently appear in cancer patients. In this sense, interventions based on acceptance and commitment therapy (ACT) show their efficacy to improve these symptoms through increased psychological flexibility, however, there is little evidence of the efficacy of ACT using combined modality (face-to-face + app), despite the fact that this application modality may have beneficial effects in this group of patients, who may see their participation in the interventions limited as a consequence of the disease. Method / design: Cancer patients will be randomly assigned to one of the following groups: (1) face-to-face ACT + app group, (2) face-to-face ACT group, and (3) group receiving usual treatment. The planned interventions last between 8 and 10 weeks and include experiential exercises, metaphors, discussions, and homework assignments to promote awareness and flexibility about thoughts and emotions associated with cancer. In the group that uses the app, exercises (mindfulness, breathing), reminder systems, recording, reinforcement and monitoring will also be provided. It is estimated that a total of 112 participants (38 per group) will be necessary, and four evaluations will be carried out: T0 (pre-treatment), T1 (post-treatment, T2 (follow-up at three months) and T3 (follow-up at six months). months). Hypothesis : The primary results that are expected to be obtained are a significant increase in the psychological flexibility of patients receiving treatment, with greater flexibility in the group receiving the combined intervention, evaluated with the AAQ-II. Furthermore, as secondary outcomes, it is expected to obtain significant improvements in anxiety and depression (HADS), quality of life (EORTC QLQ C-30), Fatigue (BFI), Insomnia (ISI) and post-traumatic growth (PTGI-SF). Hypothesis: the efficacy of the ACT-based intervention in cancer patients may be increased if the benefits of using a modality that combines face-to-face and not face-to-face are added to it.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
7mo left

Started Feb 2022

Longer than P75 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Feb 2022Dec 2026

First Submitted

Initial submission to the registry

October 27, 2021

Completed
23 days until next milestone

First Posted

Study publicly available on registry

November 19, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2022

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

May 5, 2026

Status Verified

April 1, 2026

Enrollment Period

4.2 years

First QC Date

October 27, 2021

Last Update Submit

April 28, 2026

Conditions

Keywords

CancerOncologyAcceptation and commitment therapyPsychological flexibilityRandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Mean of Psychological flexibility scores

    Acceptance and Action Questionnaire- II (AAQ-II). This instrument is designed to assess experiential avoidance and psychological inflexibility through 7 items that are answered with a Likert-type scale from 1 (never true) to 7 (always true) and a higher score indicates greater experiential avoidance (Bond et al., 2011).

    Change of mean scores of psychological flexibility from baseline to immediately after intervention

Secondary Outcomes (5)

  • Mean of Anxiety and Depression scores

    Change of mean scores of anxiety and depression from baseline to immediately after intervention

  • Mean of Quality of Life scores using EORTC QLQ C-30

    Change of mean scores of the different subscales of quality of life from baseline to immediately after intervention

  • Mean of Fatigue scores

    Change of mean scores of fatigue from baseline to immediately after intervention

  • Mean of Insomnia scores

    Change of mean scores of insomnia from baseline to immediately after intervention

  • Mean in Post-Traumatic growth scores

    Change of mean scores of post-traumatic growth from baseline to immediately after intervention

Study Arms (3)

ACT face-to-face + app

EXPERIMENTAL

Combines face-to-face ACT sessions with non-face-to-face activities and resources (mobile applications)

Behavioral: Acceptance and commitment therapy + app

ACT face-to-face

ACTIVE COMPARATOR

face-to-face ACT sessions

Behavioral: Acceptance and commitment therapy

Waitlist

NO INTERVENTION

Waitlist group. After the second assessment of the two ACT groups (at post-treatment) this group will receive the face to face ACT intervention.

Interventions

In the group ACT, experiential exercises are carried out, metaphors, discussions and assignments are used to promote awareness and flexibility about the thoughts and emotions associated with cancer

ACT face-to-face

In the group ACT+app, experiential exercises are carried out, metaphors, discussions and assignments are used to promote awareness and flexibility about the thoughts and emotions associated with cancer and interleaved non-contact activities, which will serve as support for each of the modules. The non-contact activities will consist of assigning tasks, practices (mindfulness, breathing), reminder systems, recording, reinforcement and monitoring. Resources such as short texts, videos, audio files and recording systems will be used

ACT face-to-face + app

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women, aged between 18 and 70 years.
  • Cancer diagnosis, stages I-III.
  • Cancer type: Breast / Lung / Colorectal.
  • Eligible for or currently receiving cancer treatment.
  • Ability to be fluent in Spanish.
  • Have a smartphone with daily access and basic smartphone / application management skills.
  • Access to email account and internet.
  • Not currently participating in another clinical trial.
  • Not currently receiving other psychological treatment.

You may not qualify if:

  • Men and women aged\> 70 years.
  • Diagnosis of cancer, stage IV or other types of cancer.
  • Not eligible for treatment.
  • Inability to handle himself fluently in Spanish.
  • Not having a smartphone with daily access and basic smartphone / application skills.
  • Not having access to an email account and the internet.
  • Currently participating in another clinical trial.
  • Currently receiving other psychological treatment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Reina Sofía

Córdoba, 14005, Spain

Location

Related Publications (2)

  • Garcia-Torres F, Garcia-Carmona M, Gomez-Solis A, Jurado-Gonzalez F, Jablonski M, Jaen-Moreno MJ, Aranda E. Anxiety, depression, quality of life and the mediating role of psychological flexibility: A study on Spanish cancer patients. Sci Rep. 2025 Jul 2;15(1):22530. doi: 10.1038/s41598-025-06942-6.

  • Garcia-Torres F, Gomez-Solis A, Rubio Garcia S, Castillo-Mayen R, Gonzalez Ruiz-Ruano V, Moreno E, Moriana JA, Luque-Salas B, Jaen-Moreno MJ, Cuadrado-Hidalgo F, Galvez-Lara M, Jablonski M, Rodriguez-Alonso B, Aranda E. Efficacy of a Combined Acceptance and Commitment Intervention to Improve Psychological Flexibility and Associated Symptoms in Cancer Patients: Study Protocol for a Randomized Controlled Trial. Front Psychol. 2022 May 18;13:871929. doi: 10.3389/fpsyg.2022.871929. eCollection 2022.

MeSH Terms

Conditions

Neoplasms

Interventions

AmyloidAcceptance and Commitment Therapy

Intervention Hierarchy (Ancestors)

Multiprotein ComplexesMacromolecular SubstancesProteinsAmino Acids, Peptides, and ProteinsCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study is a three-arm randomized clinical trial, with a pre-post-follow-up repeated measures intergroup design.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

October 27, 2021

First Posted

November 19, 2021

Study Start

February 1, 2022

Primary Completion

May 1, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 5, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

not applicable for this essay

Locations